INCOME STATEMENT
Eris Lifesciences Ltd.
BSE
Jun 19, 04:01
1728.75
-49.80 ( -2.80%)
Volume
5043
Prev. Close
1778.55
Open Price
1744.60
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:56
1735.80
-44.40 ( -2.49%)
Volume
85607
Prev. Close
1780.20
Open Price
1767.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
1735.80 (60)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE406M01024
|
Market Cap. ( ₹ in Cr. )
|
23641.13
|
P/BV
|
8.53
|
Book Value ( ₹ )
|
203.49
|
|
BSE Code
|
540596
|
52 Week High/Low ( ₹ )
|
1910/987
|
FV/ML
|
1/1
|
P/E(X)
|
67.19
|
|
NSE Code
|
ERISEQ
|
Book Closure
|
13/02/2025
|
EPS ( ₹ )
|
25.83
|
Div Yield (%)
|
0.42
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1663.63 | 1454.75 | 1307.12 | 1193.77 | 1088.65 |
| Other Operating Revenues | 34.12 | 31.96 | 23.61 | 21.96 | 20.19 |
| Total Operating Revenues | 1697.75 | 1486.71 | 1330.73 | 1215.73 | 1108.83 |
| | | | | | |
| Other Income | 35.51 | 34.83 | 17.26 | 28.99 | 10.00 |
| Total Revenue | 1733.26 | 1521.53 | 1347.99 | 1244.72 | 1118.83 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 68.35 | 96.29 | 114.13 | 117.57 | 99.43 |
| Purchase Of Stock-In Trade | 474.44 | 197.02 | 113.76 | 79.59 | 111.65 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -43.54 | -13.15 | 8.50 | 2.49 | -12.57 |
| Employee Benefit Expenses | 361.92 | 331.67 | 252.52 | 222.18 | 207.02 |
| Finance Costs | 220.24 | 57.42 | 20.81 | 2.99 | 0.78 |
| Depreciation And Amortisation Expenses | 181.77 | 102.39 | 64.66 | 51.46 | 37.64 |
| Other Expenses | 350.03 | 421.06 | 336.71 | 309.90 | 285.99 |
| Total Expenses | 1613.21 | 1192.70 | 911.08 | 786.18 | 729.94 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 120.05 | 328.83 | 436.91 | 458.54 | 388.89 |
| | | | | | |
| Profit/Loss Before Tax | 120.05 | 328.83 | 436.91 | 458.54 | 388.89 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 42.66 | 57.64 | 76.50 | 80.17 | 70.18 |
| Deferred Tax | 0.00 | -28.52 | -37.59 | -38.83 | -31.90 |
| Total Tax Expenses | 42.66 | 29.12 | 38.90 | 41.35 | 38.29 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 |
| | | | | | |
| Profit/Loss From Continuing Operations | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 |
| | | | | | |
| Profit/Loss For The Period | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 5.69 | 22.04 | 29.27 | 30.70 | 25.82 |
| Diluted EPS (Rs.) | 5.68 | 22.01 | 29.23 | 30.70 | 25.80 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 99.93 | 81.65 | 74.68 |
| Equity Dividend Rate (%) | 735.00 | 0.00 | 735.00 | 601.00 | 550.00 |